earnings
SE
NASDAQ · SER
Serina Therapeutics, Inc.
Healthcare · Biotechnology
$2.85
Down-$0.06 (-2.11%)
Updated Aug 14, 2026, 2:53 PM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 33.49M
- P/E ratio
- -2.49
- Dividend yield
- 0.00%
- 52-week range
- $1.22 – $3.29
- Volume
- 54.7K
- Avg. volume
- 27.05K
Price performance
SER price history
1M range · 21 trading sessions · Daily adjusted prices
SER closed at $2.85 after 21 trading sessions, up 43.94% for the selected period.
- Last close
- $2.85
- Period change
- +43.94%
- Period low
- $1.98
- Period high
- $2.85
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $2.81 | $2.85 | $2.70 | $2.85 | 54.7K |
| Aug 12, 2026 | $2.80 | $2.82 | $2.675 | $2.82 | 108.6K |
| Aug 11, 2026 | $2.69 | $2.86 | $2.68 | $2.78 | 118.07K |
| Aug 10, 2026 | $2.37 | $2.73 | $2.31 | $2.67 | 139.24K |
| Aug 7, 2026 | $2.36 | $2.40 | $2.3298 | $2.40 | 26.59K |
| Aug 6, 2026 | $2.14 | $2.39 | $2.14 | $2.35 | 70.99K |
| Aug 5, 2026 | $2.04 | $2.23 | $2.04 | $2.23 | 35.28K |
| Aug 4, 2026 | $2.11 | $2.2371 | $2.10 | $2.14 | 44.98K |
| Aug 3, 2026 | $2.00 | $2.11 | $2.00 | $2.06 | 17.64K |
| Jul 31, 2026 | $2.03 | $2.12 | $2.00 | $2.00 | 9.7K |
| Jul 30, 2026 | $2.07 | $2.11 | $2.0001 | $2.04 | 12.1K |
| Jul 29, 2026 | $2.06 | $2.12 | $2.06 | $2.07 | 6.32K |
| Jul 28, 2026 | $2.00 | $2.11 | $2.00 | $2.07 | 27.74K |
| Jul 27, 2026 | $2.11 | $2.11 | $2.00 | $2.10 | 12.55K |
| Jul 24, 2026 | $2.13 | $2.1499 | $1.98 | $2.07 | 44.32K |
| Jul 23, 2026 | $2.17 | $2.25 | $2.02 | $2.09 | 38.4K |
| Jul 22, 2026 | $2.13 | $2.281 | $2.10 | $2.17 | 68.42K |
| Jul 21, 2026 | $2.18 | $2.18 | $2.07 | $2.09 | 17.37K |
| Jul 20, 2026 | $2.13 | $2.19 | $2.04 | $2.18 | 15.62K |
| Jul 17, 2026 | $2.13 | $2.17 | $2.00 | $2.13 | 29.24K |
| Jul 16, 2026 | $2.02 | $2.06 | $1.97 | $1.98 | 31.26K |
Latest SER news
The latest Smart Investors Daily articles mentioning SER.
Stock researchCompany · Earnings
Loading stock research…